Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02825628
What this trial is testing

Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer Metastatic
DexTech Medical AB 55
Early research (Phase 1)Study completedNCT01638533
What this trial is testing

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

Who this might be right for
GliomaHematopoietic and Lymphoid Cell NeoplasmLymphoma+47 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT02713269
What this trial is testing

Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord

Who this might be right for
Malignant Digestive System NeoplasmMetastatic Head and Neck CarcinomaMetastatic Kidney Carcinoma+10 more
M.D. Anderson Cancer Center 60
Large-scale testing (Phase 3)Study completedNCT01966614
What this trial is testing

Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH

Who this might be right for
Benign Prostatic Hyperplasia
Sophiris Bio Corp 479
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876
What this trial is testing

Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors

Who this might be right for
MSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more
SOLTI Breast Cancer Research Group 184
Testing effectiveness (Phase 2)Study completedNCT03113617
What this trial is testing

68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer

Who this might be right for
Stage II Prostate AdenocarcinomaStage III Prostate AdenocarcinomaStage IV Prostate Adenocarcinoma
Andrei Iagaru 44
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Not applicableLooking for participantsNCT05000827
What this trial is testing

Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients

Who this might be right for
Prostate Cancer MetastaticProstate CancerLymph Node Metastases
Canisius-Wilhelmina Hospital 706
Post-approval studies (Phase 4)Study completedNCT00237159
What this trial is testing

Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis

Who this might be right for
Prostate Cancer Patients With Bone Metastasis
Novartis Pharmaceuticals 284
Large-scale testing (Phase 3)Looking for participantsNCT06563388
What this trial is testing

Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial

Who this might be right for
OligometastasisLung CancerColo-rectal Cancer+1 more
Roswell Park Cancer Institute 800
Large-scale testing (Phase 3)Ended earlyNCT00581113
What this trial is testing

Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases

Who this might be right for
Lung CancerBreast CancerProstate Cancer
Virginia Commonwealth University 8
Testing effectiveness (Phase 2)Ended earlyNCT03869762
What this trial is testing

Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases.

Who this might be right for
Castration-resistant Prostate CancerMetastatic CancerBone Metastases
Cancer Trials Ireland 7
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Early research (Phase 1)Active Not RecruitingNCT04485013
What this trial is testing

TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

Who this might be right for
Cancer
Tizona Therapeutics, Inc 240
Not applicableEnded earlyNCT00585117
What this trial is testing

Pilot Study of (61)CuATSM-PET Imaging in Cancer Patients

Who this might be right for
CNS Brain MetastasesHead and Neck CancerLung Cancer+2 more
University of Wisconsin, Madison 9
Large-scale testing (Phase 3)UnknownNCT06491108
What this trial is testing

Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Who this might be right for
Enlarged Prostate With Lower Urinary Tract Symptoms
Tanta University 150
Testing effectiveness (Phase 2)Study completedNCT00278993
What this trial is testing

Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior Chemotherapy

Who this might be right for
Prostate Cancer
Eisai Inc. 108
Large-scale testing (Phase 3)Looking for participantsNCT05116475
What this trial is testing

Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed Prostate Cancer With Pelvic Lymph Nodes Metastases

Who this might be right for
Prostate Cancer
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie 152
Testing effectiveness (Phase 2)UnknownNCT02484339
What this trial is testing

Treatment of Advanced Castration Resistant Prostate Carcinoma With Limited Bone Metastases (α-RT)

Who this might be right for
Prostate Carcinoma
University Hospital Freiburg 274
Large-scale testing (Phase 3)Ended earlyNCT00294437
What this trial is testing

ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases

Who this might be right for
Prostate Cancer
Central European Cooperative Oncology Group 376
Next Page